Literature DB >> 16483771

Isoquinoline derivatives as potential acetylcholinesterase inhibitors.

Sutthatip Markmee1, Somsak Ruchirawat, Vilailak Prachyawarakorn, Kornkanok Ingkaninan, Nantaka Khorana.   

Abstract

Several bisbenzylisoquinoline alkaloid derivatives showed the inhibitory activity at acetylcholinesterase enzyme (AChE) in micromolar range. It is possible that monomeric moiety of bisbenzylisoquinoline alkaloid might be required for acetylcholinesterase enzyme inhibition. AChE inhibitory activity of related monomeric 1-benzylisoquinolines was examined by using Ellman colorimetric assay with galanthamine as a reference standard.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483771     DOI: 10.1016/j.bmcl.2006.01.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations.

Authors:  Stevan Pecic; Marie A McAnuff; Wayne W Harding
Journal:  J Enzyme Inhib Med Chem       Date:  2010-06-28       Impact factor: 5.051

2.  Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae).

Authors:  Tomáš Siatka; Markéta Adamcová; Lubomír Opletal; Lucie Cahlíková; Daniel Jun; Martina Hrabinová; Jiří Kuneš; Jakub Chlebek
Journal:  Molecules       Date:  2017-07-14       Impact factor: 4.411

3.  Diverse Isoquinoline Scaffolds by Ugi/Pomeranz-Fritsch and Ugi/Schlittler-Müller Reactions.

Authors:  Yuanze Wang; Pravin Patil; Katarzyna Kurpiewska; Justyna Kalinowska-Tluscik; Alexander Dömling
Journal:  Org Lett       Date:  2019-04-29       Impact factor: 6.005

4.  Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer's Disease Pathophysiological Hallmarks.

Authors:  Sofia Benfeito; Carlos Fernandes; Santiago Vilar; Fernando Remião; Eugenio Uriarte; Fernanda Borges
Journal:  Molecules       Date:  2020-01-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.